Israel Active

(Thanks to Atid-EDI) The revolutionary Ventritek105 device from Tel Aviv’s Biosan Medical treats Intra Ventricular Hemorrhage (IVH), which has a 50% average death rate. More than 90% of the study patients treated with Ventritek105 were alive and well at the 30-day follow-up.

Another article on Weizmann Institute’s use of two diverse antibodies to target aggressive hereditary breast cancer.

(Thanks to Israel21c) Researchers at the Hebrew University of Jerusalem have discovered that flu viruses (including deadly strains) use the protein neuraminidase to disable the body’s natural killer (NK) cells. They managed to inhibit the protein and thus bolster the NK cells ability to fight the viruses.

An international team led by Weizmann Institute researchers has “turned off” the immune system’s automatic rejection of foreign transplants. They introduced the less toxic CD8+ veto immune cells into the body with the biochemical interleukin-15 to guide them to the lymph nodes.

(Thanks to Israel21c) In the last 12 years, the number of Israelis suffering from preventable blindness has been reduced by 56% - a rate unprecedented in any other country.

Britain's National Health Service (NHS) has invited Israeli life sciences companies to conduct clinical trials in the UK. This is a major achievement as the NHS is the largest single healthcare provider in the world.

Israel’s Technion signed a Memorandum of Understanding with the UK’s Manchester University that will promote joint research into cures to cancer and genetic illnesses. It will also see combined studies into heart disease, stem cell and genetic research.

Israel & Belgium based Nyxoah’s new device prevents sleep apnea by transmitting a focused electric field. It is inserted inside the chin in a simple procedure and gets its energy from an external patch that is stuck to the chin only at night. It is far more comfortable than existing alternatives.

The method of applying epidural injections hasn’t changed for 100 years. The skill of the doctor is vital with high failure rates (30%) and frequent complications. But Israel’s Omeq Medical’s sensor-based system guides the doctor to the exact spot. Over 20 million epidurals are given each year in the US alone.

(Thanks to NoCamels.com) Israel’s XPAND has a cool solution for “lazy eye” – a condition affecting around 4 percent of children. XPAND’s Amblyz eyeglasses obstruct the strong eye in automatic, intermittent intervals using an electronic shutter attached to one of the lenses.